Volition's Capture-Seq Technology Achieves 180-Fold Enrichment in Liquid Biopsy Breakthrough
VolitionRx Ltd. has developed a new method called Capture-Seq that achieves 180-fold enrichment of cancer biomarkers in blood samples, showing 100% sensitivity and specificity in early testing across several cancers including early-stage disease.
Read the full story























